Eperison Tablets (Eperisone Hydrochloride)

Adult dose

As eperisone hydrochloride, 50 mg is administered orally three times a day after meals. Adjust dosage appropriately based on age and symptoms.

This medication should not be used in patients with allergies or in those with myasthenia gravis. As this drug contains lactose, it should not be administered to patients with a genetic inability to digest lactose. Caution should be exercised when using this medication in patients with a history of drug allergies or those with impaired liver function. It can rarely cause shock, so symptoms should be closely monitored and administration should be stopped immediately if abnormalities arise. Liver function tests may show elevated levels, so liver condition should be checked periodically. It may also affect kidney function; thus, urine tests and blood tests should be performed to monitor kidney condition. Blood dyscrasias such as anemia may occur, so symptoms should be carefully observed. Allergic symptoms such as skin rash, itching, or, in severe cases, anaphylaxis may occur, requiring caution. Neurological symptoms such as insomnia, drowsiness, headaches, and numbness of the extremities may appear, necessitating communication if symptoms occur and appropriate measures should be taken. Gastrointestinal symptoms such as nausea, vomiting, loss of appetite, and abdominal pain may arise; if discomfort persists, medical consultation is advised. Urogenital symptoms, such as difficulty urinating or a feeling of incomplete bladder emptying, should be monitored for anomalies. General symptoms like lethargy, dizziness, and decreased muscle tone may occur, requiring attention. Drowsiness or decreased concentration may occur during the course of taking this medication, hence operating vehicles or hazardous machinery should be avoided. Women who are pregnant or may become pregnant should use this drug cautiously as its safety has not been established. Nursing mothers should avoid this medication whenever possible and, if it is necessary to administer, breastfeeding should be discontinued. Safety has not been thoroughly verified in children, so caution is advised due to limited usage experience. Elderly patients may have reduced bodily functions; therefore, careful management such as dose reduction may be necessary. Additionally, concurrent use of this drug with similar medications may lead to interactions such as dysregulation of blood pressure, so healthcare professionals should be informed.

Serious side effects

Shock, anaphylactic reaction, angioedema, toxic epidermal necrolysis and mucocutaneous ocular syndrome (Stevens-Johnson syndrome), liver dysfunction (elevated ALT, AST, ALP), kidney issues (proteinuria, elevated BUN), anemia.

Mild side effects

• Rash
• itching
• insomnia
• drowsiness
• headache
• paralysis of limbs
• body stiffness
• tremors of limbs
• nausea
• vomiting

This medication should be stored in a tightly closed container to prevent exposure to air or moisture, ideally at a temperature between 1 and 30 degrees Celsius. Storing it this way will help maintain the drug's effectiveness over a long period.

Appearance

White round film-coated tablets

Package unit

30 tablets/bottle, 500 tablets/bottle